Autolus

Description: Autolus pioneers CAR T cell therapies for blood cancers, reprogramming patient immune cells to target and potentially cure cancer.

Country: UK

Based in: London

Founded: 2014

Funding Stage: Series C & Beyond

Tags: ['Biopharma', 'Biotechnology', 'Medical', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.